Huaxi Biology: China Life Chengda plans to reduce its holdings by 2.00%.

Huaxi Bio Announcement: As of the disclosure date of the announcement, shareholder China Life Chengda, holding 28.9365 million shares, intends to reduce its holdings through centralized bidding by no more than 4.8168 million shares and block trades by no more than 4.8168 million shares from November 26, 2025 to February 23, 2026, totaling no more than 9.6336 million shares, with a reduction ratio of no more than 2.00%.